[THERAPEUTIC IMPORTANCE OF A NEW ORAL PENICILLIN,  3,4-DICHLORO-ALPHA-METHOXYBENZYLPENICILLIN: RIXAPEN].
D006801:Humans; D010400:Penicillin G / Q000031:analogs & derivatives; D010404:Penicillin V / Q000031:analogs & derivatives; D010406:Penicillins; D013203:Staphylococcal Infections; D013290:Streptococcal Infections
D010406:Penicillins; C010434:clometacillin; C100209:phenethicillin; D010400:Penicillin G; D010404:Penicillin V
PENICILLIN; PENICILLIN, PHENOXYMETHYL; PHENETHICILLIN; STAPHYLOCOCCAL INFECTIONS; STREPTOCOCCAL INFECTIONS
INT'ER ET TH'ERAPEUTIQUE D'UNE NOUVELLE P'ENICILLINE ORALE, LA 3-4  DICHLORO-ALPHA-M'ETHOXYBENZYLP'ENICILLINE: RIXAPEN.